How NMPA Class III Medical Device Approval Works in China
Practical primer on NMPA Class III medical device approval — classification, clinical trial, technical review, and what's different for surgical robots.
›6 articles
Practical primer on NMPA Class III medical device approval — classification, clinical trial, technical review, and what's different for surgical robots.
›How China's NMPA Innovation Green Channel works — qualification criteria, priority review benefits, and how surgical robots have used this pathway.
›NMPA numbers encode approval year, device class, and category prefix. Learn to read 国械注准/国械注进 format using real examples from Chinese medical robots.
›Eight NMPA Class III approvals, $370M+ in headline funding, and Chinese surgical robots shipping to nearly 40 countries — a review of 2025's structural shift.
›NMPA Announcement No. 63, July 2025: 10 measures to support high-end medical devices, naming surgical and rehabilitation robots as priority categories.
›WeMed Medical's ETcath received NMPA approval March 21, 2025, becoming China's first fully domestically developed robot for percutaneous coronary intervention.
›